All In Biotech

Drug Trial Radar · NCT07293260

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial

A Double-blind, Randomized, Placebo-controlled, Multi-center Study Evaluating the Safety, Tolerability, and Effect of Olpasiran on Coronary Artery Plaque Burden Assessed by Coronary Computed Tomography Angiography in Participants With Stable Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a)

Last checked: Nov 19, 2026Latest source record: Apr 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 406 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

406

Planned (sponsor's estimate)

Start

Mar 23, 2026

Primary completion

Jun 15, 2028

Study completion Jun 15, 2028

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Dec 19, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 35 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this trial is to evaluate the effect of olpasiran, compared to placebo, on non-calcified plaque (NCP) volume as measured by Coronary Computed Tomography Angiography (CCTA).

Conditions

  • Cardiovascular Disease

Interventions

  • OlpasiranDrug

    Olpasiran will be administered SC.

  • PlaceboDrug

    Placebo will be administered SC.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in NCP Volume from Baseline to Week 72Time frame: Baseline to Week 72

Locations

40 sites in 11 countries. Site status is shown where the registry gives one.

  • Bridgeport Hospital

    Bridgeport, Connecticut · Recruiting

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida · Recruiting

  • Midwest Heart and Vascular Specialists

    Overland Park, Kansas · Recruiting

  • Flourish Bowie

    Bowie, Maryland · Recruiting

  • Montefiore Medical Center - Bronx

    Philadelphia, Pennsylvania · Recruiting

  • Vital Heart and Vein

    Humble, Texas · Recruiting

  • Advara HeartCare Wesley

    Auchenflower, Queensland, Australia · Recruiting

  • University of The Sunshine Coast Clinical Trials, Sippy Downs

    Sippy Downs, Queensland, Australia · Recruiting

  • Advara HeartCare Leabrook

    Leabrook, South Australia, Australia · Recruiting

  • North York Diagnostic and Cardiac Centre

    Vaughan, Ontario, Canada · Recruiting

  • Peking University First Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China · Recruiting

  • The Second Xiangya Hospital of Central South University

    Changsha, Hunan, China · Recruiting

  • The Third Xiangya Hospital of Central South University

    Changsha, Hunan, China · Recruiting

  • The Second Affiliated Hospital of Nanjing Medical University

    Nanjing, Jiangsu, China · Recruiting

  • General Hospital of Ningxia Medical University

    Yinchuan, Ningxia, China · Recruiting

  • Shaanxi Provincial Peoples Hospital

    Xi'an, Shaanxi, China · Recruiting

  • Jinan Central Hospital

    Jinan, Shandong, China · Recruiting

  • Regionshospitalet Gødstrup

    Herning, Denmark · Recruiting

  • Regionshospitalet Viborg

    Viborg, Denmark · Recruiting

  • Centre Hospitalier Universitaire de Nice - Hopital Pasteur

    Nice, France · Recruiting

  • Centre Hospitalier Universitaire de Bordeaux Hopital Haut-Leveque

    Pessac, France · Recruiting

  • Centre Hospitalier Universitaire de Toulouse - Hopital Rangueil

    Toulouse, France · Recruiting

  • Centre Hospitalier Regional Universitaire de Tours - Hopital Trousseau

    Tours, France · Recruiting

  • Charite - Universitaetsmedizin Berlin, Campus Benjamin Franklin

    Berlin, Germany · Recruiting

  • Universitaetsklinikum Essen

    Essen, Germany · Recruiting

  • Universitaetsklinikum Frankfurt

    Frankfurt am Main, Germany · Recruiting

  • Klinikum rechts der Isar der TUM

    München, Germany · Recruiting

  • Azienda Ospedaliera Universitaria di Ferrara Arcispedale Sant Anna

    Ferrara, Italy · Recruiting

  • IRCCS Centro Cardiologico Monzino

    Milan, Italy · Recruiting

  • IRCCS Policlinico San Donato

    San Donato Milanese, Italy · Recruiting

  • Azienda Ospedaliera Ordine Mauriziano di Torino

    Torino, Italy · Recruiting

  • Tomakomai City Hospital

    Tomakomai-shi, Hokkaido, Japan · Recruiting

  • Osaka Keisatsu Hospital

    Osaka, Osaka, Japan · Recruiting

  • University of Yamanashi Hospital

    Chuo-shi, Yamanashi, Japan · Recruiting

  • Tergooiziekenhuizen, locatie Hilversum

    Hilversum, Netherlands · Recruiting

  • Hospital Universitario Ramon y Cajal

    Madrid, Spain · Recruiting

  • Hospital Universitario Virgen Macarena

    Seville, Andalusia, Spain · Recruiting

  • Hospital Alvaro Cunqueiro

    Vigo, Galicia, Spain · Recruiting

  • Hospital Universitari i Politecnic La Fe

    Valencia, Valencia, Spain · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.